Shareholder Alert: Ademi LLP investigates whether Renovacor, Inc. has obtained a Fair Price in its transaction with Rocket Pharmaceuticals, Inc.

Provided By PR Newswire

Last update: Sep 21, 2022

MILWAUKEE, Sept. 21, 2022 /PRNewswire/ -- Ademi LLP is investigating Renovacor ( NYSE: RCOR) for possible breaches of fiduciary duty and other violations of law in its transaction with Rocket Pharmaceuticals.